vs

Side-by-side financial comparison of Arbe Robotics Ltd. (ARBE) and Strive, Inc. (ASST). Click either name above to swap in a different company.

Arbe Robotics Ltd. is the larger business by last-quarter revenue ($458.0K vs $255.0K, roughly 1.8× Strive, Inc.). Arbe Robotics Ltd. runs the higher net margin — -2218.6% vs -75406.7%, a 73188.1% gap on every dollar of revenue.

Arbe Robotics Ltd. is an Israeli technology company that develops 4D imaging radar chipsets and perception solutions for advanced driver-assistance systems (ADAS) and autonomous vehicles. Headquartered in Tel Aviv, it is listed on the Nasdaq Stock Market and the Tel Aviv Stock Exchange under the ticker symbol ARBE.

Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.

ARBE vs ASST — Head-to-Head

Bigger by revenue
ARBE
ARBE
1.8× larger
ARBE
$458.0K
$255.0K
ASST
Higher net margin
ARBE
ARBE
73188.1% more per $
ARBE
-2218.6%
-75406.7%
ASST

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ARBE
ARBE
ASST
ASST
Revenue
$458.0K
$255.0K
Net Profit
$-10.2M
$-192.3M
Gross Margin
-16.6%
Operating Margin
-2528.8%
-17288.6%
Net Margin
-2218.6%
-75406.7%
Revenue YoY
-74.1%
Net Profit YoY
-2726.9%
EPS (diluted)
$-0.09
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARBE
ARBE
ASST
ASST
Q4 25
$458.0K
Q3 25
$254.0K
$255.0K
Q2 25
$274.0K
$173.3K
Q1 25
$170.7K
Q4 24
$212.8K
Q3 24
$123.0K
$984.0K
Q2 24
$93.0K
Q1 24
$124.8K
Net Profit
ARBE
ARBE
ASST
ASST
Q4 25
$-10.2M
Q3 25
$-11.0M
$-192.3M
Q2 25
$-10.2M
$-8.9M
Q1 25
$-3.7M
Q4 24
$-4.1M
Q3 24
$-12.6M
$-6.8M
Q2 24
$-5.9M
Q1 24
$-4.8M
Gross Margin
ARBE
ARBE
ASST
ASST
Q4 25
-16.6%
Q3 25
-95.7%
Q2 25
-67.5%
Q1 25
Q4 24
Q3 24
-220.3%
Q2 24
Q1 24
Operating Margin
ARBE
ARBE
ASST
ASST
Q4 25
-2528.8%
Q3 25
-4531.9%
-17288.6%
Q2 25
-4189.8%
-1553.9%
Q1 25
-970.5%
Q4 24
-5889.5%
Q3 24
-10119.5%
-712.4%
Q2 24
-1857.2%
Q1 24
-1110.9%
Net Margin
ARBE
ARBE
ASST
ASST
Q4 25
-2218.6%
Q3 25
-4344.5%
-75406.7%
Q2 25
-3707.3%
-5122.4%
Q1 25
-2195.6%
Q4 24
-1935.5%
Q3 24
-10222.8%
-691.3%
Q2 24
-6313.1%
Q1 24
-3837.7%
EPS (diluted)
ARBE
ARBE
ASST
ASST
Q4 25
$-0.09
Q3 25
$-0.10
$-0.22
Q2 25
$-0.09
$-0.17
Q1 25
$-0.13
Q4 24
$-5.62
Q3 24
$-0.19
$-3.06
Q2 24
$-0.58
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARBE
ARBE
ASST
ASST
Cash + ST InvestmentsLiquidity on hand
$44.7M
$109.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.6M
$779.4M
Total Assets
$73.8M
$792.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARBE
ARBE
ASST
ASST
Q4 25
$44.7M
Q3 25
$52.3M
$109.1M
Q2 25
$6.6M
$2.5M
Q1 25
$4.2M
Q4 24
$6.2M
Q3 24
$18.8M
$2.1M
Q2 24
$1.9M
Q1 24
$1.9M
Stockholders' Equity
ARBE
ARBE
ASST
ASST
Q4 25
$39.6M
Q3 25
$49.1M
$779.4M
Q2 25
$58.0M
$10.7M
Q1 25
$19.6M
Q4 24
$23.3M
Q3 24
$17.2M
$27.5M
Q2 24
$5.4M
Q1 24
$11.3M
Total Assets
ARBE
ARBE
ASST
ASST
Q4 25
$73.8M
Q3 25
$66.1M
$792.6M
Q2 25
$75.8M
$3.3M
Q1 25
$5.0M
Q4 24
$28.2M
Q3 24
$55.5M
$2.6M
Q2 24
$2.4M
Q1 24
$2.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARBE
ARBE
ASST
ASST
Operating Cash FlowLast quarter
$-9.0M
$-14.0M
Free Cash FlowOCF − Capex
$-9.0M
FCF MarginFCF / Revenue
-1974.7%
Capex IntensityCapex / Revenue
6.3%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARBE
ARBE
ASST
ASST
Q4 25
$-9.0M
Q3 25
$-11.1M
$-14.0M
Q2 25
$-11.8M
$-1.7M
Q1 25
$-1.6M
Q4 24
$-21.6M
Q3 24
$-7.8M
$-13.2M
Q2 24
$-1.3M
Q1 24
$-1.0M
Free Cash Flow
ARBE
ARBE
ASST
ASST
Q4 25
$-9.0M
Q3 25
$-11.3M
Q2 25
$-11.8M
Q1 25
Q4 24
$-21.6M
Q3 24
$-7.9M
$-13.4M
Q2 24
$-1.3M
Q1 24
$-1.1M
FCF Margin
ARBE
ARBE
ASST
ASST
Q4 25
-1974.7%
Q3 25
-4448.8%
Q2 25
-4319.3%
Q1 25
Q4 24
-10161.2%
Q3 24
-6408.9%
-1360.3%
Q2 24
-1379.4%
Q1 24
-844.7%
Capex Intensity
ARBE
ARBE
ASST
ASST
Q4 25
6.3%
Q3 25
60.2%
0.0%
Q2 25
21.5%
Q1 25
Q4 24
11.3%
Q3 24
96.7%
18.8%
Q2 24
3.1%
Q1 24
9.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons